Find us on:
Site Map
Main Menu
- Home
- About Us
- About LDNscience
- In the News
- Revamped LDN site launched -- biggest patient-initiated drug discovery program in history
- LDNscience® Media Release - New Website Aims to Clear Up Misconceptions About Breakthrough Drug Low Dose Naltrexone (LDN)
- MedInsight® Announces Clinical Trial Results of Low-dose Naltrexone; Potential Breakthrough For Crohn's Disease Patients
- Our People
- Our Supporters
- LDN
- What is LDN?
- LDN Discovery Timeline
- How Does LDN Work?
- What is LDN Used for?
- LDN Researchers
- Dr. Amol Soin
- Dr. Brian Johnson
- Dr. Burton Berkson, M.D., M.S., Ph.D.
- Dr. Gabriela Dieckmann
- Dr. Guttorm Raknes, M.D., Ph.D.
- Dr. Ian S. Zagon, Ph.D.
- Dr. Jarred Younger, Ph.D.
- Dr. Jill P. Smith, M.D.
- Dr. Leonard Weinstock, M.D.
- Dr. Maira Gironi, M.D.
- Dr. Mark Shukhman, M.D.
- Dr. Patricia J. McLaughlin, Ph.D.
- Dr. Scott Zashin
- Dr. Sean Mackey, M.D., Ph.D.
- Dr. Wai Liu, Ph.D.
- Moshe Rogosnitzky
- Prof. Angus Dalgleish, M.D., F.R.C.P., F.R.A.C.P., F.R.C.Path, F.Med.Sci
- Research
- Safety and efficacy of low dose naltrexone in a long covid cohort; an interventional pre-post study
- Recalcitrant cases of Hailey-Hailey disease successfully managed with low-dose naltrexone
- The role of immune modulation and anti-inflammatory agents in the management of prostate cancer: A case report of six patients.
- Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?
- Reversible Hair Loss in Lichen Planopilaris: Regrowth With Low-Dose Naltrexone and Platelet-Rich Plasma
- Low-dose naltrexone for treatment of burning mouth syndrome
- Use of Off-Label Drugs and Nutrition Supplements among Patients with Amyotrophic Lateral Sclerosis in Norway
- The State-of-the-art Pharmacotherapeutic Options for the Treatment of Chronic Non-Cancer Pain
- Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study
- Depression in Fibromyalgia Patients May Require Low-Dose Naltrexone to Respond: A Case Report
- Combination of cannabidiol with low dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo.
- Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19.
- Naltrexone at low doses (LDN) and its relevance to cancer therapy
- Topical Therapeutic Options in Corneal Neuropathic Pain
- Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial.
- Effect of Low-Dose Naltrexone on Egyptian Children with Intractable Epilepsy: A Case Series Study
- Metronomic chemotherapy for advanced diffuse hepatocellular carcinoma in a dog
- Timing of treatment with an endogenous opioid alters immune response and spinal cord pathology in female mice with experimental autoimmune encephalomyelitis.
- Prurigo excoriée treated with low dose naltrexone
- Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells
- LDN Protects Bone Property Deterioration at Different Hierarchical Levels in T2DM Mice Bone
- Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment
- Low Dose Naltrexone in Endometrial Intraepithelial Neoplasia
- Low-Dose Naltrexone Use for Patients with Complex Regional Pain Syndrome: A Systematic Literature Review
- Low Dose Naltrexone in Conjunction With the Wahls Protocol to Reduce the Frequency of Chronic Migraines in a Patient With Multiple Sclerosis: A Case Study
- Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and Beta-Endorphin.
- Efficacy and safety of low-dose naltrexone in painful diabetic neuropathy: A randomized, double-blind, active-control, crossover clinical trial
- Chromatin protein HMGB1 regulates hyperinsulinemia mediated insulin resistance: low-dose naltrexone rescues insulin resistance associated with hyperinsulinemia
- Management of Pediatric Complex Regional Pain Syndrome with Low-Dose Naltrexone
- Utilization of Low-Dose Naltrexone for Burning Mouth Syndrome: A Case Report
- A Review of the Integrative Treatment Approach Using the Intravenous Alpha-Lipoic Acid/Low Dose Naltrexone (ALA/N) Protocol for Cancer and a Description of the Long-Term Survival of a Woman with Hepatocellular Carcinoma
- Pilot study of tolerability and safety of opioid receptor antagonists as novel therapies for chronic pain among persons living with HIV with past year heavy drinking: a randomized controlled trial
- The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
- Low-dose naltrexone plays antineoplastic role in cervical cancer progression through suppressing PI3K/AKT/mTOR pathway.
- Low Doses Naltrexone: The Potential Benefit Effects for its Use in Patients with Cancer
- Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with Neuropathic Corneal Pain
- Improvement in Hailey–Hailey disease with a combination of low-dose naltrexone and oral magnesium chloride: A case report
- Naltrexone's Impact on Cancer Progression and Mortality: A Systematic Review of Studies in Humans, Animal Models, and Cell Cultures
- Use of low-dose naltrexone in the management of chronic pain conditions: A systematic review.
- Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone
- Perspectives on Low Dose Naltrexone Use in Treatment of Autoimmune Pathology and Endometriosis
- Low-Dose Naltrexone for the Treatment of Fibromyalgia: Investigation of Dose-Response Relationships
- [Met 5]-enkephalin preserves diffusion metrics in EAE mice
- No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study.
- Low dose naltrexone rescues inflammation and insulin resistance associated with hyperinsulinemia
- Naltrexone a potential therapeutic candidate for COVID-19
- Dual Opioid Systems: A Simpler Explanation for Naltrexone Efficacy in Fibromyalgia
- Low-Dose Naltrexone Reverses Facial Mechanical Allodynia in a Rat Model of Trigeminal Neuralgia
- Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo
- Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review
- Vulvar Hailey-Hailey disease treated with low-dose naltrexone: case report and literature review.
- Sjogren's Syndrome and Clinical Benefits of Low-Dose Naltrexone Therapy: Additional Case Reports
- Efficacy of Low Dose Naltrexone in Psoriasis
- Efficacy and Tolerability of Low-dose Naltrexone for Pain Relief among Neuropathic Corneal Pain Patients
- Hailey-Hailey Disease Successfully Treated with Low-Dose Naltrexone
- The efficacy and safety of oral low dose naltrexone versus placebo in the patients with lichen planopilaris; a randomized controlled clinical trial.
- Erythromelalgia in a Patient with Mast Cell Activation Syndrome: Response to Low Dose Naltrexone
- Low-dose Naltrexone Therapy for Psoriasis
- Naltrexone Hydrochloride 1.5-mg and 4.5-mg Capsules
- Low-dose naltrexone in Hailey-Hailey disease: the importance of dosing.
- Low-dose naltrexone inhibits colorectal cancer progression and promotes apoptosis by increasing M1-type macrophages and activating the Bax/Bcl-2/caspase-3/PARP pathway.
- Enkephalin Therapy Improves Relapsing-Remitting Multiple Sclerosis
- The Lowdown on Low-Dose Naltrexone
- Improvement of Hailey-Hailey disease with low-dose naltrexone
- Low-Dose Naltrexone reduces symptoms in Stiff-Person Syndrome
- Low-dose naltrexone as a treatment for chronic fatigue syndrome
- The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response
- Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
- Low-dose naltrexone safe, effective for neuropathic corneal pain
- Changes in the consumption of antiepileptics and psychotropic medicines after starting low dose naltrexone: A nation-wide register-based controlled before-after study
- Low-dose naltrexone-induced remission in Hailey–Hailey disease maintained in remission with topical combination of ketamine and diphenhydramine
- A Retrospective Review of Patients Prescribed Low Dose Naltrexone for Chronic Pain at a Single Institution
- Hailey-Hailey disease treated successfully with naltrexone and magnesium.
- Low-dose naltrexone: a novel adjunctive treatment in symptomatic alopecias?
- Interaction of opioid growth factor (OGF) and opioid antagonist and their significance in cancer therapy
- Naltrexone for the Treatment of Darier and Hailey-Hailey Diseases.
- Low-dose naltrexone: a unique treatment for amyopathic dermatomyositis
- Low-dose naltrexone therapy in benign chronic pemphigus (Hailey-Hailey disease): a case series.
- Use of low-dose naltrexone in the treatment of severe Hailey-Hailey disease: one case report.
- Low Dose Naltrexone for Neuropathic Pain Related to an Electrical Burn Injury: A Case Study
- Low-Dose Naltrexone in the Treatment of Fibromyalgia: A Retrospective Analysis
- Inexpensive compounding of low dose naltrexone (LDN) with orange juice.
- Systemic administration of low-dose naltrexone increases bone mass due to blockade of opioid growth factor receptor signaling in mice osteoblasts.
- Pharmacology Update: Low-Dose Naltrexone as a Possible Nonopioid Modality for Some Chronic, Nonmalignant Pain Syndromes
- The use of naltrexone in dermatology. Current evidence and future directions.
- Disease remission after commencing naltrexone in an atypical case of Crohn’s disease complicated by recurrent Clostridium difficile infection
- Low Dose Naltrexone: A Viable Alternative for Long Term Chronic Pain?
- Sjogren's Syndrome: Clinical Benefits of Low-dose Naltrexone Therapy
- Low Dose Naltrexone in Dermatology
- Low dose naltrexone: Effects on medication in rheumatoid and seropositive arthritis. A nationwide register-based controlled quasi-experimental before-after study.
- Variable response to low-dose naltrexone in patients with Darier disease: a case series.
- Treating chronic pain with low dose naltrexone and ultralow dose naltrexone: a review paper.
- Naltrexone and Scopolamine Rapidly Reduce Symptoms of Major Depressive Disorder (MDD): A Double Blinded Randomized Controlled Pilot Study
- Low-dose Naltrexone: An Alternative Treatment for Erythrodermic Psoriasis
- Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis.
- The Use of Low-Dose Naltrexone for Chronic Pain
- The Uses of Naltrexone in Dermatological Conditions
- Intermittent blockade of OGFr and treatment of autoimmune disorders
- Utility of Naltrexone Treatment for Chronic Inflammatory Dermatologic Conditions: A Systematic Review
- Clinical Utility of the Cold Pressor Test: Evaluation of Pain Patients and Treatment of Opioid-Induced Hyperalgesia and Fibromyalgia with Low Dose Naltrexone
- The effect of naltrexone as a carboplatin chemotherapy-associated drug on the immune response, quality of life and survival of dogs with mammary carcinoma
- Successful treatment of dermatomyositis with low-dose naltrexone
- Low-Dose Naltrexone (LDN)-Review of Therapeutic Utilization
- Treatment of psoriasis vulgaris using low-dose naltrexone
- Generalized familial benign chronic pemphigus (Hailey-Hailey disease) treated successfully with low-dose naltrexone
- Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report
- Low Dose Naltrexone and Lung Cancer: A Case Report and Discussion
- Double-blinded placebo-controlled cross-over pilot trial of naltrexone to treat Gulf War Illness
- Low-dose naltrexone (LDN): A promising treatment in immune-related diseases and cancer therapy
- The Use and Utility of Low-dose Naltrexone Capsules for Patients with Fibromyalgia
- Off-Label, Low-Dose Naltrexone for Treatment of Systemic Polyneuropathy of Unknown Origin
- Low Dose Naltrexone in the Management of Ehlers-Danlos Syndrome Associated Pain
- Low Dose Naltrexone as a Treatment for Chronic Pain
- Low dose Naltrexone for induction of remission in inflammatory bowel disease patients
- The safety and efficacy of low-dose naltrexone in the management of chronic pain and inflammation in multiple sclerosis, fibromyalgia, Crohn's disease, and other chronic pain disorders.
- The effect of Low Dose Naltrexone on Medication in Inflammatory Bowel Disease: A Quasi Experimental before-and-after Prescription Database Study
- Emerging Unconventional Therapies for Alopecia Areata
- Variable Response to Naltrexone in Patients With Hailey-Hailey Disease
- Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment
- Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis
- The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol.
- Endogenous Opioids in the Etiology and Treatment of Multiple Sclerosis
- Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris
- Quench the Fire! A Case Report of Burning Mouth Syndrome Treated with Low Dose Naltrexone After Failure of Response to Extensive Pain Management Trials
- Psychoneuroimmunological approach to gastrointestinal related pain
- Low dose naltrexone in multiple sclerosis: Effects on medication use. A quasi-experimental study
- Neuropathic Corneal Pain: Approaches for Treatment
- Low dose naltrexone: a novel treatment for Hailey-Hailey disease
- Low-dose Naltrexone for the treatment of sarcoidosis
- Successful Treatment of Adult-Onset Dermatitis Herpetiformis with Low Dose Naltrexone
- Serum [Met5]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone.
- Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone
- Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease)
- Repurposing Medications—Chicken Manure, Erectile Dysfunction, and Finding the Golden Needle in the Haystack of Absurdity
- Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors
- Alteration of prescription-only drug utilization by low dose naltrexone users with hypothyroidism. A cohort study based on the Norwegian prescription database from 2011-2015
- Use of low dose naltrexone and change in use of prescription drugs in patients with inflammatory bowel disease – A drug utilization cohort study based on the Norwegian prescription register
- In patients with fibromyalgia, is low-dose naltrexone effective in alleviating pain, and does it decrease use of oral opioids?
- Hailey–Hailey disease successfully controlled with low-dose naltrexone
- Potential antidepressant role of low-dose naltrexone in a rat model of chronic unpredictable mild stress
- Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
- Potential drug interaction with opioid agonist in the setting of chronic low-dose opioid antagonist use.
- Low-dose naltrexone and opioid consumption: a drug utilization cohort study based on data from the Norwegian prescription database
- Low Dose Naltrexone in the Treatment of Fibromyalgia
- Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants.
- A sudden and unprecedented increase in low dose naltrexone (LDN) prescribing in Norway. Patient and prescriber characteristics, and dispense patterns. A drug utilization cohort study.
- Long-term treatment with low dose naltrexone maintains stable health in patients with multiple sclerosis
- Functional modulation on macrophage by low dose naltrexone (LDN)
- Could Low-Dose Naltrexone be an Effective Treatment for Hailey-Hailey Disease?
- Combination of Metabolic Treatment of Aggressive Primary Brain Tumour and Multiple Metastases of the Brain
- Evaluation of Therapeutic Effect of Low Dose Naltrexone in Experimentally-Induced Crohn's Disease in Rats
- Naltrexone at low doses upregulates a unique gene expression not seen with normal doses: Implications for its use in cancer therapy
- Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients
- Low Dose Naltrexone Reduces In Vitro Endoplasmic Reticulum Stress and Stimulates Wound Healing in Intestinal Epithelial Cells
- A novel glial cell inhibitor, low dose naltrexone, reduces pain and depression, and improves function in chronic pain: A CHOIR study
- Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4.
- Etiological Pathways Toward Autism and Diversities of Treatments: From Unimodal to Multidimensional Approaches
- Identification and Treatment of New Inflammatory Triggers for Complex Regional Pain Syndrome: Small Intestinal Bacterial Overgrowth and Obstructive Sleep Apnea
- Immuno-regulatory effects on murine macrophages by low dose naltrexone (LDN)
- Opioid growth factor and low dose naltrexone impair central nervous system infiltration by CD4+T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis
- Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy
- No Antagonists for an Antagonist: One Pitfall of Chronic Oral Low-Dose Naltrexone No Antagonists for an Antagonist
- Effects of low-dose naltrexone on feed intake, growth, endocrine and immune parameters in the recently-weaned pig
- Low-Dose Naltrexone in newly diagnosed high-grade glioma: placebo-controlled, double-blind, randomized pilot study
- Low Dose Naltrexone (LDN): New in the treatment of chronic pain syndromes. What really matters – reduced pain or increased energy?
- Treatment of clinically isolated syndrome with Low Dose Naltrexone
- Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis
- Low Dose Naltrexone for Treatment of Multiple Sclerosis: A Retrospective Chart Review of Safety and Tolerability
- Duration of Opioid Receptor Blockade Determines Biotherapeutic Response
- Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
- Low Dose Naltrexone in refractory neuropathic pain associated with autoimmune transverse myelitis
- A potential anti-inflammatory effect of low-dose naltrexone in fibromyalgia
- Low Dose Naltrexone in the Treatment of Crohn's Disease: A Case Series
- Low Dose Naltrexone Treatment of Established Relapsing-Remitting Experimental Autoimmune Encephalomyelitis
- Low Dose Naltrexone in the treatment of dissociative symptoms
- Fibromyalgia, autism, and opioid addiction as natural and induced disorders of the endogenous opioid hormonal system
- Long-term remission of adenoid cystic tongue carcinoma with Low Dose Naltrexone and vitamin D3--a case report
- Naltrexone Therapy for Crohn’s Disease and Ulcerative Colitis
- Off-Label Low-Dose Naltrexone for Refractory Chronic Back Pain
- Effects of systemic opioid receptor ligands on ethanol- and sucrose seeking and drinking in alcohol-preferring (P) and Long Evans rats.
- The use of Low-Dose Naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain
- Low Dose Naltrexone for induction of remission in Crohn's disease
- Metabolic treatment of cancer: intermediate results of a prospective case series
- Low Dose Naltrexone in therapy resistant IBD, a case series
- Low Dose Naltrexone (LDN) enhances maturation of bone marrow dendritic cells (BMDCs)
- Low-Dose Naltrexone Therapy Improves Active Ulcerative Colitis
- Apparent Efficacy and Safety of Low Dose Naltrexone in Australian Patients with Active Crohn's Disease
- Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment
- Treatment of Complex Regional Pain Syndrome (CRPS) using Low Dose Naltrexone (LDN)
- Low Dose Naltrexone in the treatment of Fibromyalgia
- Safety and tolerability of Low-Dose Naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study
- Low-Dose Naltrexone for normalizing immune system function
- Low-Dose Naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels
- Is fibromyalgia an endocrine/endorphin deficit disorder? Is Low Dose Naltrexone a new treatment option?
- Efficacy of low dose naltrexone for patients that suffer from comorbid depressive disease
- Immunological changes in IBD patients responding to low-dose naltrexone treatment
- Single cohort study of the effect of Low Dose Naltrexone on the evolution of immunological, virological and clinical state of HIV+ adults in Mali
- Impact of Low Dose Naltrexone (LDN) on antiretroviral therapy (ART) treated HIV+ adults in Mali: A single blind randomized clinical trial
- Low-Dose Naltrexone (LDN) Treatment for Crohn's Disease (CD): A Tertiary Care Center Experience
- Low-Dose Naltrexone for pruritus in systemic sclerosis
- Low-dose naltrexone: Tricking the body to heal itself
- The opioid growth factor (OGF) and Low Dose Naltrexone (LDN) suppress human ovarian cancer progression in mice.
- Therapy with the Opioid Antagonist Naltrexone Promotes Mucosal Healing in Active Crohn’s Disease: A Randomized Placebo-Controlled Trial
- Low-Dose Naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin
- Low dose naltrexone LDN: Harnessing the body's own chemistry to treat human ovarian cancer
- Low Dose Naltrexone: A Possible Safe Effective Treatment for AutoImmune Disease and Cancer
- Enhancing acupuncture by Low Dose Naltrexone
- The Long Term Suppression of Experimental Autoimmune Encephalomyelitis by the Opioid Growth Factor and Low Dose Naltrexone
- Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis
- ALSUntangled No. 8: Low Dose Naltrexone for ALS
- Low-Dose Naltrexone for treatment of duodenal Crohn's disease in a pediatric patient
- The effect of Low-Dose Naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial
- Low-Dose Naltrexone's Tolerability and Effects in Fatigued Patients with Parkinson's Disease: An Open-Label Study
- Low Dose Naltrexone: Side Effects and Efficacy in Gastrointestinal Disorders
- Pilot trial of Low Dose Naltrexone and quality of life in MS
- Revisiting the ALA/N (alpha-lipoic acid/Low-Dose Naltrexone) protocol for people with metastatic and non-metastatic pancreatic cancer: a report of 3 new cases
- Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis
- Fibromyalgia symptoms are reduced by Low-Dose Naltrexone: a pilot study
- Low-Dose Naltrexone for disease prevention and quality of life
- Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: Involvement of toll-like receptor 4 (TLR4).
- A pilot trial of Low-Dose Naltrexone in primary progressive multiple sclerosis
- Reversal of signs and symptoms of a B-cell lymphoma in a patient using only Low-Dose Naltrexone
- Low-Dose Naltrexone therapy improves active Crohn's disease
- Low-Dose Naltrexone for the treatment of irritable bowel syndrome: a pilot study
- Bee Venom Therapy and Low Dose Naltrexone for Treatment of Multiple Sclerosis
- The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/Low-Dose Naltrexone protocol
- Low-Dose Naltrexone for multiple sclerosis and autism: Does its benefit reveal a common cause?
- Low Dose Naltrexone therapy in multiple sclerosis
- Inhibition of human colon cancer by intermittent opioid receptor blockade with Naltrexone
- Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors
- Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems
- Endogenous opioid systems regulate cell proliferation in the developing rat brain
- Modulation of murine neuroblastoma in nude mice by opioid antagonists
- Opioid antagonist-induced regulation of organ development
- Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth
- Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer
- Naltrexone modulates growth in infant rats
- Opioid antagonists inhibit the growth of metastatic murine neuroblastoma
- Naltrexone modulates tumor response in mice with neuroblastoma
- Patients
- Resources
- Interviews with Experts
- LDN for CRPS: FDA Orphan Drug Designation and Beyond
- LDN for Sjögren's Syndrome
- LDN for Psoriasis and Psoriatic Arthritis
- LDN for Rheumatoid Arthritis
- LDN for Fibromyalgia
- LDN's Anti-Cancer Effects
- LDN's Surprising Effects on Sexual Dysfunction, Addiction and Mental Illness
- LDN transforms a country: Interview with health expert Dr. Guttorm Raknes
- Having a Choice: Successful Use of LDN for Difficult-To-Treat Cancers and AutoImmune Diseases
- LDN's Impact on Infertility, AutoImmune Disease and Epigenetics
- Using LDN to treat GI Disorders, Restless Legs Syndrome, and Sarcoidosis
- LDN’s Potential As Adjuvant Therapy for All Cancers
- Thirty Five Years of LDN Research at Penn State University
- The Discovery of Low Dose Naltrexone
- Use of LDN As A Potential Treatment For Multiple Sclerosis
- Use of Low Dose Naltrexone in Fibromyalgia
- Interviews with Patients
- Big Energy Influx: LDN's Alleviated Engineer Elsa Hashimoto's Thyroiditis
- Vicki 4 Years Later: Celebrating 16 Years on LDN for MS
- "A Life-Changer": LDN's improves Brooke's kidney disorder and much more
- Driving & Surfing: How LDN Changed Tia's Life by Improving her CRPS
- "My drug of choice": How 28 years of taking LDN has changed Bill's MS prognosis
- A Future Back on Track: LDN Helps Kat Recover from RA (and improves her ADHD!)
- LDN is a miracle, and a lifesaver: Tom's recovery from extreme eczema
- Sarah's LDN Self-Advocacy Pays Off In A Health Turnaround
- LDN Helped Smokey's Childbirth-Like Abdominal Pain
- LDN Family Success Story: Alleviating Fran's Dementia and Yeti the Cat's Pancreatic Cancer
- "Miraculous is Not an Overstatement": Sandy's Turnaround from CVID and Sjogren's
- "LDN Really Is For The Dogs!": Rocky's Cancerous Tumors Disappear
- "She's Like A Puppy Again!": Maggie's Recovery from Arthritis & a Torn ACL
- Cindy & Alan: "LDN is The Best Health Decision We've Ever Made"
- "I Feel Decades Younger": Alan's Relief from Osteoarthritis
- "LDN Has Given Me My Life Back": Cindy's Recovery from Sjogren's & Burning Mouth Syndromes
- Dolly The Rescue Poodle's LDN Story: Beating The Odds Against Sinus Cancer
- Unexpected Healing: Steve Took LDN for Hashimoto's and It Resolved His Severe Sinusitis/Allergies Too
- Finally Off The Couch: LDN Relieved Laura's Interstitial Cystitis
- "No More Bobbling Head!": LDN Alleviates Pami's Cervical Dystonia
- LDN Restored Quality of Life for Kim (and Her Service Dogs!)
- Osteoarthritis Pain Calmed Down Overnight: Deb's LDN Success Story
- "I Am So Grateful": LDN Helped Kayleen's Rheumatoid Arthritis
- It Was A Godsend! LDN Helped Vicki Recover from Debilitating MS Symptoms
- I Can Live Again! LDN Dramatically Reduced Tim's Severe Chronic Back Pain, Making Opiates Obsolete
- LDN Saved My Hearing: Sue's Autoimmune Hearing Loss Healed With LDN
- Ruth's "miracle": Fibromyalgia relieved and tough skin disorder 99% gone with LDN
- LDN Turns Around the Life of a Sufferer of Restless Legs Syndrome
- How A Struggle With Lupus/RA Ended With LDN
- Brought Back from the Brink: LDN Helps Regulate a Life Consumed by Bipolar Disease
- LDN Facilitated a Remarkable Recovery from the Damage of Multiple Sclerosis
- A Life Decimated by Pain: LDN Gave a Fibromyalgia Sufferer Her Life Back
- Ten Years of Uncontrolled Hashimoto's: A Wild Ride Became Smooth With LDN
- 3rd Party LDN Website Links
- Interviews with Experts
Footer 3 - Menu
- Questions & Answers
- Our Supporters
- Find an LDN Prescriber
- Where to Buy LDN
- Terms of Service
- Contact Us
- Site Map
- Lp
- Low Dose Naltrexone (LDN) is making great strides: Three new clinical trials launched
- 2019: Best Year Yet for LDN Research!
- MS (Multiple Sclerosis) and LDN
- Understanding MS (Multiple Sclerosis)
- LDN and MS (Multiple Sclerosis) - Clinical Trials and Studies Review
- Survey reveals real patient experiences with LDN
- A Fresh Breakthrough by the Discoverers of LDN - Solving the Mystery of How LDN Treats Multiple Sclerosis
- LDN Offers Fresh Hope for IBD Patients
- LDN Chosen as First Choice for Treating Fibromyalgia and CFS/ME Pain
- Low Dose Naltrexone (LDN) Unexpectedly Benefits Infertility
- LDN for Eye Disorder: Neuropathic Corneal Pain
- LDN Can Help Mental Illness
- Slowing Down Hashimoto’s with Low Dose Naltrexone (LDN)
- Fibromyalgia Sufferers May “Get Their Lives Back” with LDN
- CRPS Pain Scores Decrease with Low-Dose Naltrexone
- Low Dose Naltrexone Provides Relief for Ill Animals
- LDN’s Effects on Sleep
- LDN & Immunosuppressants
- 2018 was truly amazing for the LDN community!
- LDN Publications - 2019 Q1
- LDN’s Effects on Multiple Kinds of Pain
- LDN for Skin Disorders
- The Pain Our Pets Feel: Can LDN help?
Copyright 2009-
MedInsight® Research Institute.
All rights reserved.
MedInsight® Research Institute.
All rights reserved.
About LDNscience®
LDNscience® is a public information project of the MedInsight® Research Institute.
MedInsight® Research Institute is a U.S./U.K. based non-profit organization which serves as a platform for researching and indexing available off-label (repurposed) treatments for cancer and chronic diseases.
Sign up for news alerts
MedInsight's Projects:
Dipyridamole Eye Drops
Cureiosity®
